Trial intelligence / Profile preview

Albuterol versus albuterol + budesonide nebulization for neonatal respiratory distress syndrome

IRCT2016111617413N22Phase 3Completed

Sponsor
Islamic Azad University
Start
Sep 2015
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of salbutamol and budesonide in respiratory distress syndrome (RDS) (2 arms), sponsored by Islamic Azad University. Started Sep 2015; status: completed.

02

Drugs

salbutamolbudesonide
03

Conditions

respiratory distress syndrome (RDS)

Beyond the preview

Go deeper on IRCT2016111617413N22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016111617413N22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call